Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Assets Average (2019 - 2025)

10x Genomics' Assets Average history spans 7 years, with the latest figure at $1.0 billion for Q4 2025.

  • For Q4 2025, Assets Average rose 11.44% year-over-year to $1.0 billion; the TTM value through Dec 2025 reached $1.0 billion, up 11.44%, while the annual FY2025 figure was $980.0 million, 4.05% up from the prior year.
  • Assets Average for Q4 2025 was $1.0 billion at 10x Genomics, up from $1.0 billion in the prior quarter.
  • Across five years, Assets Average topped out at $1.0 billion in Q4 2025 and bottomed at $911.0 million in Q1 2025.
  • The 5-year median for Assets Average is $976.6 million (2021), against an average of $974.7 million.
  • The largest annual shift saw Assets Average surged 61.89% in 2021 before it decreased 7.58% in 2024.
  • A 5-year view of Assets Average shows it stood at $1.0 billion in 2021, then rose by 0.79% to $1.0 billion in 2022, then decreased by 5.51% to $956.8 million in 2023, then dropped by 2.99% to $928.2 million in 2024, then rose by 11.44% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for TXG's Assets Average are $1.0 billion (Q4 2025), $1.0 billion (Q3 2025), and $941.7 million (Q2 2025).